FundaMental Pharma
Mathias Frederiksen - Director
Neuroscience
Heidelberg, Germany
FundaMental Pharma is a neuroscience company developing NMDA/TRPM4 interface inhibitors to stop neurodegeneration, restore function, and maintain brain health.
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.